跳至主要内容
临床试验/CTRI/2020/10/028622
CTRI/2020/10/028622已完成2 期

Individualized Homoeopathic Medicines in Treatment of Rheumatoid Arthritis: Double-blind, Randomized, Placebo-controlled, Pilot Trial

The Calcutta Homoeopathic Medical College and Hospital0 个研究点目标入组 54 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
54

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1. Patients having scored 6 or higher according to the ACR (American College of Rheumatology) criteria for classification of rheumatoid arthritis.
  • 2. Patients of either sex.
  • 3. Age between 18-65 years.
  • 4. Patients with known but controlled systemic diseases are also eligible for the study.
  • 5. Literate patients; ability to read Bengali and/or English.
  • 6. Patients giving written consent to participate in the study.

排除标准

  • 1. Patients with psychiatric diseases
  • 2. Cases suffering from uncontrolled systemic illness, life-threatening infections, or any vital organ failure
  • 3. Cases already undergoing homoeopathic treatment for any chronic purpose since last 6 months
  • 4. Substance abuse and/or dependence
  • 5. Self-reported immune-compromised state
  • 6. Women during pregnancy, puerperium and lactation

研究者

发起方
The Calcutta Homoeopathic Medical College and Hospital

相似试验